Effect of Nicotine on Brain Reward Pathways



Status:Completed
Conditions:Depression, Depression
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 45
Updated:4/17/2018
Start Date:February 2015
End Date:November 2017

Use our guide to learn which trials are right for you!

The investigators will determine whether an acute dose of nicotine, in the form of the
nicotine lozenge, impacts brain and behavioral measures of mood and reward responsiveness in
individuals with major depressive disorder.


Inclusion Criteria for subjects with Major Depressive Disorder:

1. Provide written informed consent;

2. Both genders and all ethnic origins, age between 18 and 45;

3. Meet DSM-IV diagnostic criteria for MDD (diagnosed with the use of the SCID);

4. A baseline HAM-D score of 16 or greater;

5. Absence of pregnancy;

6. Absence of any psychotropic medication for at least 2 weeks:

1. 6 weeks for fluoxetine

2. 6 months for neuroleptics

3. 2 weeks for benzodiazepines

4. 2 weeks for any other antidepressants

Inclusion Criteria for Healthy Controls

1. Absence of medical, neurological, and psychiatric illness (including alcohol and
substance abuse); as assessed by subject history and a structured clinical interview
(SCID);

2. Provide written informed consent;

3. Both genders and all ethnic origins, age between 18 and 45;

4. Absence of any medications for at least 3 weeks;

5. Absence of pregnancy.

Exclusion Criteria:

1. Subjects with suicidal ideation where outpatient treatment is determined unsafe. These
patients will be immediately referred to a licensed psychologist or psychiatrist to
determine the appropriate clinical treatment;

2. Serious or unstable medical illness

3. Lifetime history of seizure disorder;

4. Lifetime history or current diagnosis of any of the following DSM-IV psychiatric
illnesses: organic mental disorder, schizophrenia, schizoaffective disorder,
delusional disorder, psychotic disorders not otherwise specified, bipolar disorder,
ADHD, patients with mood congruent or mood incongruent psychotic features; simple
phobia, social anxiety disorder and generalized anxiety disorders will be allowed only
if secondary to MDD;

5. Patients with a lifetime history of electroconvulsive therapy (ECT);

6. Failure to meet standard MRI safety requirements;

7. May not have used any nicotine product in the past year; must report fewer than 20
lifetime uses of nicotine

8. Must have an expired carbon monoxide level of less than or equal to 10 ppm.

9. Use of anticholinergic drugs in the past week

10. Any past or present history of cardiac problems including known arrhythmias, acute
coronary syndrome, or ischemic heart disease

11. Uncontrolled hypertension

12. History of substance abuse in the past 6 months (other than caffeine), self-reported
use of marijuana in past month, or history of treatment with methadone

13. Heavy caffeine users (consume greater than 500 mg on a regular or daily basis)

14. Subjects that cannot speak English
We found this trial at
1
site
115 Mill St
Belmont, Massachusetts 02478
(617) 855-2000
Phone: 617-855-3244
McLean Hospital McLean Hospital is a comprehensive psychiatric hospital committed to providing easy access to...
?
mi
from
Belmont, MA
Click here to add this to my saved trials